Wire · opportunities
Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 13 October 2026 · Fusion42 review
Agilent Technologies announced its definitive agreement to acquire Proscia, a digital pathology software provider, for $240 million plus up to $30 million in performance milestones. The acquisition enhances Agilent’s pathology portfolio by integrating Proscia’s AI-enabled digital pathology platform, expanding its offerings in pathology instrumentation, reagents, and software to support clinical and life-sciences markets.
This Wire brief sits within Fusion42's coverage of Health, and 4 sources have reported it between 13 Oct 2026 and 14 Oct 2026.
◆ ◆ The Wire takeaway
You can no longer rely on classic pathology tools alone. Proscia’s AI-powered platform now has the backing of a major lab instruments supplier, opening a fast route to scale digital pathology workflows for clinical and pharma customers.
◆ Coverage
4 sources · first reported 13 Oct 2026 · latest 14 Oct 2026
◆ Related on Wire
◆ Topics